We are monitoring the impact of COVID-19 & Recession alarm on North America In-Vitro Toxicology Testing Market Get in touch with us for detailed analysis Know More
Share on

North America In-Vitro Toxicology Testing Market Research Report – Segmented By Product, Type, Toxicity Endpoints & Tests, Technology, Method, Industry and Country(the United States, Canada, Mexico and Rest of North America) – Analysis on Size, Share, Trends, Growth, Forecast (2022 to 2027)

Published: January, 2022
ID: 171
Pages: 135

North America In-vitro Toxicology Testing Market Size (2022 to 2027)

The size of the In-vitro Toxicology Testing Market in North America is expected to reach USD 11609.64 Million by 2027 from USD 6117.72 Million in 2022, growing at a CAGR of 13.67% from 2022 to 2027. Rise in the number of R & D procedures, which require in vitro testing, restrictions on animal testing, and an increase in awareness about environmental concerns are the major factors driving the North America In-Vitro toxicology testing market. 

In-vitro toxicology testing is the scientific analysis of toxic effects produced by chemical substances on cultured mammalian cells or bacteria. Toxicity testing is essential in drug discovery as it identifies the poisonous effects of a new compound in the early stages of drug discovery. This early detection of toxicity reduces the development cost and time.

Favorable regulatory authorities for toxicology testing using the in-vitro tests, growing technological advancements in toxicity testing models, increasing research & development expenditure towards cell culture are primarily fuelling the market growth. The existence of stringent regulations related to animal utilization for toxicity testing and growing demand for in-vitro tests to drive the growth of the in-vitro toxicology testing market in North America. However, the requirement of extensive validation procedures for new in-vitro methods and the presence of stringent social & scientific laws about toxicology testing studies are some of the factors that restrain the growth of the in-vitro toxicology testing market North America.

This research report segmented and sub-segmented into the following categories:

  • By Product: Assays, Reagents and Labware & Services
  • By Type: ADME, Dose & Toxic Substance
  • By Toxicity Endpoints & Tests: Carcinogenicity, Dermal Toxicity, and Genotoxicity
  • By Technology: OMICS Technologies and Cell Culture Technology
  • By Method: Cellular Assays and In-Silico Method
  • By Industry: Cosmetics & Household Products and Pharmaceutical
  • By Country: The United States, Canada, Mexico and Rest of North America

Based on geographical areas, the U.S. is estimated to account for a more significant share of the North America in-vitro toxicology testing market in 2019. In contrast, Canada is expected to grow at a higher CAGR during the forecast period.

The U.S. In-vitro Toxicology Testing Market

In 2019, the United States accounted for the most significant market share in North America. Developments in the genetics and genetic screening approaches and the emergence of new approaches of 3D cell culture are majorly helping the U.S. market. 

Moreover, supportive government authority has led to the fast development of new, cost-effective testing for establishing drug, device, chemical, and cosmetic safety in the United States. The ideal increase in investment in instruments and the ongoing expansion of laboratory capabilities, across the region, currently, enable the consumer to establish toxicological profiles of medical devices, biopharmaceuticals, cosmetics, and chemicals. These investments contain a widen the existing cell/tissue culture power, and mass spectrometry facilities, flow cytometry, other than the launching of high throughput screening, multiplexing technologies, and automation for biomarker examination. 

Most promising companies operating in the North American In-Vitro Toxicology Testing Market profiled in the report are Covance, Inc. (A subsidiary of LabCorp) (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Eurofins Scientific SE (Luxembourg), General Electric Company (U.S.), BioReliance, Inc. (U.S.), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.) and Cyprotex (U.K.).

1. Introduction                                                                                 

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1          Product                                                               

                                5.1.1 Introduction                                                           

                                5.1.2 Assays                                                       

                                5.1.3 Reagents & Labware                                                           

                                5.1.4 Services     Growth Hormone Therapy                                         

                5.2          Type                                                     

                                5.2.1 Introduction                                                           

                                5.2.2 ADME (Absorption, Distribution, Metabolism, and Excretion)                                                          

                                5.2.3 Dose                                                          

                                5.2.4 Toxic Substance                                                    

                5.3          Toxicity Endpoints & Tests                                                          

                                5.3.1 Introduction                                                           

                                5.3.2 Systemic Toxicity                                                  

                                5.3.3 Dermal Toxicity                                                     

                                5.3.4 Carcinogenicity                                                      

                                5.3.5 Ocular Toxicity                                                       

                                5.3.6 Skin Sensitization & Irritation                                                          

                                5.3.7 Genotoxicity                                                          

                                5.3.8 Neurotoxicity                                                         

                                5.3.9 Organ Toxicity                                                        

                                5.3.10 Other Toxicity Endpoints & Tests                                                

                5.4          Technology                                                        

                                5.4.1 Introduction                                                           

                                5.4.2 OMICS Technologies                                                           

                                5.4.3 Cell Culture Technology                                                     

                                5.4.4 High-Throughput Technologies                                                      

                                5.4.5 Molecular Imaging Technologies                                                   

                5.5          Method                                                              

                                5.5.1 Introduction                                                           

                                5.5.2 In-Silico Methods                                                 

                                5.5.3 Biochemical Assays                                                              

                                5.5.4 Cellular Assays                                                       

                                5.5.5 Ex-Vivo Models                                                     

                5.6          Industry                                                              

                                5.6.1 Introduction                                                           

                                5.6.2 Cosmetics and Household Products                                                             

                                5.6.3 Diagnostics                                                              

                                5.6.4 Pharmaceuticals                                                   

                                5.6.5 Food Industry                                                        

                                5.6.6 Chemicals                                                

6. Geographical Analysis                                                                                              

                                6.1 Introduction                                                               

                                6.2 United States                                                            

                                6.3 Canada                                                         

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 Covance, Inc.  (A subsidiary of LabCorp) (U.S.)                                                            

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Agilent Technologies, Inc. (U.S.)                                                        

                8.3 Bio-Rad Laboratories, Inc. (U.S.)                                                        

                8.4 Eurofins Scientific SE (Luxembourg)                                                 

                8.5 General Electric Company (U.S.)                                                       

                8.6 BioReliance, Inc. (U.S.)                                                      

                8.7 Charles River Laboratories International, Inc. (U.S.)                                                  

                8.8 Thermo Fisher Scientific, Inc. (U.S.)                                                 

                8.9 Catalent (U.S.)                                                          

                8.10 Cyprotex (U.K.)                                                      

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Expert Opinions                                                                                        

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

Appendix                                                                                           

                a) List of Tables                                                                

                b) List of Figures                                                                              

 

  1. North America In-Vitro Toxicology Testing Market, By Region, From 2022 - 2027 (USD Million)
  2. North America In-Vitro Toxicology Testing Market, By Product, From 2022 - 2027 (USD Million)
  3. North America Assays Market, By Region, From 2022 - 2027 (USD Million)
  4. North America Reagents & Labware Market, By Region, From 2022 - 2027 (USD Million)
  5. North America Services Market, By Region, From 2022 - 2027 (USD Million)
  6. North America In-Vitro Toxicology Testing Market, By Type, From 2022 - 2027 (USD Million)
  7. North America ADME (Absorption, Distribution, Metabolism, and Excretion)  Market, By Region, From 2022 - 2027 (USD Million)
  8. North America Dose  Market, By Region, From 2022 - 2027 (USD Million)
  9. North America Toxic Substance Market, By Region, From 2022 - 2027 (USD Million)
  10. North America In-Vitro Toxicology Testing Market, By Toxicity Endpoints & Tests, From 2022 - 2027 (USD Million)
  11. North America Systemic Toxicity Market, By Region, From 2022 - 2027 (USD Million)
  12. North America Dermal Toxicity Market, By Region, From 2022 - 2027 (USD Million)
  13. North America Carcinogenicity Market, By Region, From 2022 - 2027 (USD Million)
  14. North America Ocular Toxicity  Market, By Region, From 2022 - 2027 (USD Million)
  15. North America Skin Sensitization & Irritation  Market, By Region, From 2022 - 2027 (USD Million)
  16. North America Genotoxicity  Market, By Region, From 2022 - 2027 (USD Million)
  17. North America Neurotoxicity  Market, By Region, From 2022 - 2027 (USD Million)
  18. North America Organ Toxicity Market, By Region, From 2022 - 2027 (USD Million)
  19. North America Other Toxicity Endpoints & Tests Market, By Region, From 2022 - 2027 (USD Million)
  20. North America In-Vitro Toxicology Testing Market, By Technology, From 2022 - 2027 (USD Million)
  21. North America OMICS Technologies  Market, By Region, From 2022 - 2027 (USD Million)
  22. North America Cell Culture Technology Market, By Region, From 2022 - 2027 (USD Million)
  23. North America High-Throughput Technologies Market, By Region, From 2022 - 2027 (USD Million)
  24. North America Molecular Imaging Technologies Market, By Region, From 2022 - 2027 (USD Million)
  25. North America In-Vitro Toxicology Testing Market, By Method, From 2022 - 2027 (USD Million)
  26. North America In-Silico Methods  Market, By Region, From 2022 - 2027 (USD Million)
  27. North America Biochemical Assays Market, By Region, From 2022 - 2027 (USD Million)
  28. North America Cellular Assays  Market, By Region, From 2022 - 2027 (USD Million)
  29. North America Ex-Vivo Models Market, By Region, From 2022 - 2027 (USD Million)
  30. North America In-Vitro Toxicology Testing Market, By Industry , From 2022 - 2027 (USD Million)
  31. North America Cosmetics and Household Products  Market, By Region, From 2022 - 2027 (USD Million)
  32. North America Diagnostics  Market, By Region, From 2022 - 2027 (USD Million)
  33. North America Pharmaceuticals  Market, By Region, From 2022 - 2027 (USD Million)
  34. North America Food Industry  Market, By Region, From 2022 - 2027 (USD Million)
  35. North America  Chemicals Market, By Region, From 2022 - 2027 (USD Million)
  36. United States In-Vitro Toxicology Testing Market, By Product, From 2022 - 2027 (USD Million)
  37. United States In-Vitro Toxicology Testing Market, By Type, From 2022 - 2027 (USD Million)
  38. United States In-Vitro Toxicology Testing Market, By Toxicity Endpoints & Tests, From 2022 - 2027 (USD Million)
  39. United States In-Vitro Toxicology Testing Market, By Technology, From 2022 - 2027 (USD Million)
  40. United States In-Vitro Toxicology Testing Market, By Method, From 2022 - 2027 (USD Million)
  41. United States In-Vitro Toxicology Testing Market, By Industry , From 2022 - 2027 (USD Million)
  42. Canada In-Vitro Toxicology Testing Market, By Product, From 2022 - 2027 (USD Million)
  43. Canada In-Vitro Toxicology Testing Market, By Type, From 2022 - 2027 (USD Million)
  44. Canada In-Vitro Toxicology Testing Market, By Toxicity Endpoints & Tests, From 2022 - 2027 (USD Million)
  45. Canada In-Vitro Toxicology Testing Market, By Technology, From 2022 - 2027 (USD Million)
  46. Canada In-Vitro Toxicology Testing Market, By Method, From 2022 - 2027 (USD Million)
  47. Canada In-Vitro Toxicology Testing Market, By Industry , From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample